Nanomaterials 12 00856
Nanomaterials 12 00856
Nanomaterials 12 00856
Article
Loaded n-Hydroxyapatite/SSG 3D Scaffolds as a Drug Delivery
System of Nigella sativa Fractions for the Management of Local
Antibacterial Infections
Mohammed Dalli 1, * , Abdelqader El Guerraf 2 , Salah-eddine Azizi 1 , Karim Benataya 2 , Ali Azghar 3 ,
Jeong Mi-Kyung 4 , Adil Maleb 3 , Kim Bonglee 5,6, * and Nadia Gseyra 1
Abstract: As a result of their close similarities to the inorganic mineral components of human
bone, hydroxyapatite nanoparticles (n-HAp) are widely used in biomedical applications and for
Citation: Dalli, M.; El Guerraf, A.; the elaboration of biocompatible scaffold drug delivery systems for bone tissue engineering. In this
Azizi, S.-e.; Benataya, K.; Azghar, A.; context, a new efficient and economic procedure was used for the consolidation of n-HAp in the
Mi-Kyung, J.; Maleb, A.; Bonglee, K.; presence of various Nigella sativa (NS) fractions at a near-room temperature. The research conducted
Gseyra, N. Loaded n-Hydroxyapatite/ in the present study focuses on the physicochemical properties of loaded n-HAp 3D scaffolds by
SSG 3D Scaffolds as a Drug Delivery
NS fractions and the in vitro antibacterial activity against Gram-negative (Escherichia coli ATCC
System of Nigella sativa Fractions for
25922, Pseudomonas aeruginosa ATCC 27853, Klebsiella pneumoniae ATCC 27853), and Gram-positive
the Management of Local
(Staphylococcus aureus ATCC 29213, Enterococcus faecalis ATCC 700603) bacteria. In order to better
Antibacterial Infections.
Nanomaterials 2022, 12, 856. https://
understand the effect of the inserted fractions on the HAp molecular structure, the elaborated samples
doi.org/10.3390/nano12050856 were subject to Fourier transform infrared (FTIR) and X-ray diffraction (XRD) spectroscopic analyses.
In addition, the morphological investigation by scanning electron microscope (SEM) of the loaded
Academic Editor: Hangrong Chen
n-HAp 3D scaffolds demonstrated the presence of a porous structure, which is generally required
Received: 17 January 2022 in stimulating bone regeneration. Furthermore, the fabricated 3D composites exhibited significant
Accepted: 28 February 2022 antibacterial activity against all tested bacteria. Indeed, MIC values ranging from 5 mg/mL to
Published: 3 March 2022 20 mg/mL were found for the HAp-Ethanol fraction (HAp-Et) and HAp-Hexane fraction (HAp-Hex),
Publisher’s Note: MDPI stays neutral
while the HAp-Aqueous fraction (HAp-Aq) and HAp-Methanol fraction (HAp-Me) showed values
with regard to jurisdictional claims in between 20 mg/mL and 30 mg/mL on the different strains. These results suggest that the HAp-NS
published maps and institutional affil- scaffolds were effective as a drug delivery system and have very promising applications in bone
iations. tissue engineering.
2.6. Characterization
2.6.1. XRD
The phases of the consolidated composites with different fractions were characterized
through X-ray diffraction (XRD, XRD-6000, SHIMADZU, Kyoto, Japan) in the range of 2θ,
an angle of 10–65◦ using Cu Kα radiation (λ = 0.154 nm), and a scanning speed of 4◦ /s.
The crystallite size of the (002) plane was estimated by the Scherrer formula, as follows:
Kλ
D= (1)
β cos θ
D represents the crystallite size (nm); K is the Scherrer constant (k = 0.89); β is the
half-width height of the diffraction peak; and θ is the diffraction angle of the associated
(hkl) plane.
2.6.2. FTIR
Fourier-transform infrared (FTIR) analysis in attenuated total reflection (ATR) mode is
used for complementary structure identification. The experiment was conducted using a
Jasco 4700-ATR spectrophotometer in the spectral range between 4000 and 500 cm−1 with a
4 cm−1 resolution.
2.6.3. SEM
The microstructure of elaborated loaded composites was observed by scanning elec-
tron microscopy (FE-SEM) using a JEOL-JSM7001F apparatus. The working distance was
maintained at 6 mm (the distance between the sample and the objective lens remains) and
the SEM filament was operated at variable currents and a voltage of 5 kV using differ-
ent magnifications. The elemental composition was determined using an X-ray energy
dispersive spectroscopy (EDS).
Figure 2. ATR-FTIR (A) and XRD patterns (B) of consolidated samples. (a) HAp-Aq, (b) HAp-Me,
(c) HAp-Et, and (d) HAp-Hex.
On the other hand, SEM investigation was achieved to describe the resulting structure
of the 3D composites. The micrographs of various NS fraction-loaded composites are
presented in Figure 3. For comparison, the analysis was also achieved for non-loaded
n-HAp/SSG and the images are gathered in the same figure. As shown, the morphology
of n-HAp is affected by the introduced molecules. Indeed, each NS fraction interacts
differently with HAp, giving various topographies.
The SEM revealed a compact and homogeneous structure where n-HAp particles are
totally integrated within the SSG material (Figure 3A). Hence, this results in the formation
of a high number of pores spread equally throughout the 3D surface. After the modification
of n-HAp/SSG, each introduced NS fraction presents a specific morphology. It can be
seen that the fraction prepared with methanol solvent (HAp-Me) can block some of the
pores. As shown, a smooth coating layer has formed, which covers the entire outer surface
of n-HAp/SSG (Figure 3C). However, many micropores with a diameter generally lower
than 50 µm are still present. On the other hand, the aqueous-, ethanol-, and hexane-based
fractions demonstrate the presence of randomly distributed and interconnected micro-
porosity (Figure 3B,D,E). To obtain a comprehensive understanding of the pore space of
the samples under investigation, the histogram of the pore size distribution, plotted using
processed SEM micrographs from ImageJ, is presented in Figure 4. The specimens display
a unimodal distribution with a mean pore size of 68.63 µm. In fact, the pore diameters
ranged between 10 and 200 µm for practically all elaborated loaded scaffolds.
Commonly, the presence of abundant irregular open and interconnected pores on the
outer and inner surfaces of a biomaterial is an important key for industrial applications.
This interesting property has a crucial role in stimulating bone regeneration, as it provides
a great ability to induce osteointegration and improve implant adhesion to the host tissue.
Nanomaterials 2022, 12, 856 7 of 14
Figure 3. SEM micrographs and the corresponding EDS patterns of consolidated samples.
(A) HAp/SSG, (B) HAp-Aq, (C) HAp-Me, (D) HAp-Et and (E) HAp-Hex.
The EDS analysis of the NS-based composite scaffolds, presented in the same figure,
clearly indicates the presence of calcium (Ca) and phosphorus (P) from the n-HAp particles,
and silicon (Si) and sodium (Na) resulted from the precipitated sodium silicate glass.
Additionally, carbon (C) and oxygen (O) can be associated with either n-HAp or SSG.
By comparison to the atomic percentage of carbon in n-HAp/SSG before and after the
integration of NS fractions, we note an important increase in the organic matter in our
composites. Indeed, C% of about 9.9% was obtained for the unmodified composite (as
shown in Figure 3 from our previous paper [14]); it passes to 27%, 28%, 25%, and 32% for
HAp-Aq, HAp-Me, HAp-Et, and HAp-Hex, respectively.
Figure 4. Statistical histogram of the pore size distribution derived from the SEM micrographs.
The agar diffusion method was used for testing the antibacterial capacity of the differ-
ent NS fractions. The results obtained for the 3D HAp scaffold-free fractions demonstrate
no activity on the tested strains, while loading the 3D scaffolds with aqueous, methanol,
ethanol, and n-hexane fractions showed that all strains were sensitive toward all n-HAp
scaffolds. Due to the fact that the HAp 3D scaffolds free of any additional fraction have no
effect, the antibacterial activity was attributed to the NS fractions.
Concerning the MIC and MBC values, the results are depicted in Table 2. The different
MIC values were ranging from 5 to 20 mg/mL, while the MBC values were from 5 to
50 mg/mL.
Nanomaterials 2022, 12, 856 9 of 14
Table 2. MIC and MBC in mg/mL of Nigella sativa-loaded fractions in HAp 3D scaffolds against
tested bacteria.
The present study aimed to investigate the antibacterial activity of different n-HAp-
loaded scaffolds with different NS fractions obtained from Soxhlet apparatus by using a
new consolidation technique. According to our previous studies, it was mentioned that
the NS seeds are of great richness with phenolic and flavonoid compounds [21]. For exam-
ple, the aqueous fraction was found to be rich in vanillic acid, ferulic acid, salicylic acid,
vanillin, and rutin (Figure 5A(1)). In addition, the MeOH fraction was characterized by
the presence of gallic acid, vanillic acid, rutin, and naringenin (Figure 5A(2)), while the
EtOH fraction was rich with three flavonoids (rutin, catechin, kaempferol) (Figure 5A(3)).
On the other hand, the n-hexane methyl ester was distinguished by the presence of thy-
moquinone, linoleic acid, palmitic acid, carvacrol, and stearic acid, with different amounts
(Figure 5B) [26].
Regarding the antibacterial activity, the results obtained indicate that the different
tested fractions are endowed with a strong antibacterial activity that could be attributed to
the bioactive compounds present in each fraction. The smallest MIC value was registered
in Gram-positive bacteria (S. aureus and E. faecalis) with a value of 5 mg/mL in HAp-
Hex and HAp-Et. The highest MIC value was 30 mg/mL for E. faecalis and 20 mg/mL
for the other bacteria. From the results, it was observed that the Gram-positive bacteria
were very sensitive to the n-HAp-Hex and n-HAp-Et, while the Gram-negative bacteria
were less sensitive to the tested fractions. This difference in response between the Gram-
positive bacteria and the Gram-negative bacteria is principally due to the morphology of
the bacterial wall. The Gram-positive bacteria are characterized by their richness with
peptidoglycans, which facilitate the passage of hydrophobic molecules to the inside of the
bacteria. The Gram-negative bacteria wall is rich with lipopolysaccharides, which allow
the passage of the hydrophilic molecules from the external environment to the internal
environment [33].
In a study performed on the methanolic extract of NS, it was noted that the extract
exerts a strong activity on S. aureus, while it was inactive on K. pneumoniae. In the same
context, Zuridah et al. [34] demonstrated a weak activity on E. coli and P. aeruginosa. These
findings were different when compared with our results, where the MeOH fraction was
able to inhibit the K. pneumoniae, E. coli, and P. aeruginosa at an MIC value of 20 mg/mL.
Regarding the black cumin ethanolic extract tested on bacteria that alter food, it
was shown that this extract inhibits the bacteria S. aureus and E. coli, with no effect on
K. pneumoniae growth [35], which was contradictory to our findings, where the EtOH
fraction showed a great inhibitory potential toward all strains tested with an MIC value
ranging from 5 to 20 mg/mL. The study of Khalid et al. [36] demonstrated that the aqueous
extract has a weak antibacterial activity toward S. aureus, E. coli, P. aeruginosa, and E. faecalis,
while in the present study it was demonstrated that all tested strains manifested a high
sensitivity to the NS aqueous fraction. Concerning the n-hexane fraction, the MIC values
ranged from 5 to 20 mg/mL, which was close to those obtained in the Abraham et al.
study [37].
Nanomaterials 2022, 12, 856 10 of 14
Figure 5. HPLC profiles of the different tested fractions (A) and the total ion chromatogram of the
n-hexane fraction (B). (1) aqueous fraction, (2) methanol fraction and (3) ethanol fraction.
Several studies have reported the antibacterial potential of the different molecules
identified in our fractions. For example, the salicylic acid present in our aqueous fraction
was found to be endowed with an important inhibitory activity on different bacteria such
as S. aureus, E. coli, P. aeruginosa, and E. faecalis with an MIC (250–500 µg/mL). In the
same study, it was registered that the quercetin present in our MeOH fraction, and the
kaempferol present in our EtOH and aqueous fractions, were found to play a moderate
antibacterial role with an MIC value of about 500–1000 µg/mL. Moreover, the rutin was
found to be capable of inhibiting the different strains tested with an MIC ranging between
500 and 1000 µg/mL [38]. The two phenolic acids (gallic and ferulic acids) were reported
to exhibit an important antibacterial activity on different bacteria such as S. aureus, E. coli,
and P. aeruginosa, with an MIC value between 100 and 1750 µg/mL. It was also noted that
exposure to gallic acid and ferulic acid induced membrane damage in the tested bacterial
strains [39]. The catechin present in our MeOH, EtOH, and aqueous fractions was revealed
Nanomaterials 2022, 12, 856 11 of 14
of new applications in the medical field. The use of these bioactive compounds loaded
in hydroxyapatite/SSG composite in bone reconstruction could help in the amelioration
of the health state by reducing the number of postoperative infections after the implants.
More studies are in progress in order to investigate, in vivo, the capacity of the loaded
hydroxyapatite 3D scaffolds.
Author Contributions: Conceptualization, M.D. and N.G.; methodology, M.D.; software, A.E.G.;
validation, S.-e.A., A.A. and J.M.-K.; formal analysis, K.B. (Karim Benataya); investigation, M.D.;
resources, K.B. (Karim Benataya); data curation, M.D. and A.E.G.; writing—original draft preparation,
M.D.; writing—review and editing, M.D. and A.E.G.; visualization, A.M.; supervision, N.G.; funding
acquisition, K.B. (Kim Bonglee). All authors have read and agreed to the published version of
the manuscript.
Funding: This research was supported by Korea Institute of Oriental Medicine: KSN2021240, Basic
Science Research Program through the National Research Foundation of Korea (NRF) funded by the
Ministry of Education (NRF-2020R1I1A2066868), the National Research Foundation of Korea (NRF)
grant funded by the Korea government (MSIT) (No. 2020R1A5A2019413).
Institutional Review Board Statement: Not applicable.
Informed Consent Statement: Not applicable.
Data Availability Statement: Data are available within the article.
Acknowledgments: The authors would like to thank LEGSSYER Bouchra and LAKRAT Mohammed
for their precious help during this study.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Lowe, B.; Hardy, J.G.; Walsh, L.J. Optimizing Nanohydroxyapatite Nanocomposites for Bone Tissue Engineering. ACS Omega
2020, 5, 1–9. [CrossRef] [PubMed]
2. Zhang, Y.; Rehmmann, L. Extraction of high-value compounds from marine biomass via ionic liquid-based techniques. In
Innovative and Emerging Technologies in the Bio-Marine Food Sector; Elsevier: Amsterdam, The Netherlands, 2022; pp. 417–439.
3. Zhou, H.; Lee, J. Nanoscale hydroxyapatite particles for bone tissue engineering. Acta Biomater. 2011, 7, 2769–2781. [CrossRef]
[PubMed]
4. Zhao, R.; Xie, P.; Zhang, K.; Tang, Z.; Chen, X.; Zhu, X.; Fan, Y.; Yang, X.; Zhang, X. Selective effect of hydroxyapatite nanoparticles
on osteoporotic and healthy bone formation correlates with intracellular calcium homeostasis regulation. Acta Biomater. 2017, 59,
338–350. [CrossRef]
5. Liu, H.; Huang, L.H.; Sun, X.Y.; Ouyang, J.M. High-phosphorus environment promotes calcification of A7R5 cells induced by
hydroxyapatite nanoparticles. Mater. Sci. Eng. C 2020, 107, 110228. [CrossRef]
6. Ezhaveni, S.; Yuvakkumar, R.; Rajkumar, M.; Sundaram, N.M.; Rajendran, V. Preparation and characterization of nano-
hydroxyapatite nanomaterials for liver cancer cell treatment. J. Nanosci. Nanotechnol. 2013, 13, 1631–1638. [CrossRef]
7. Mohammadpour, Z.; Majidzadeh-A, K. Applications of Two-Dimensional Nanomaterials in Breast Cancer Theranostics. ACS
Biomater. Sci. Eng. 2020, 6, 1852–1873. [CrossRef] [PubMed]
8. Dey, S.; Das, M.; Balla, V.K. Effect of hydroxyapatite particle size, morphology and crystallinity on proliferation of colon cancer
HCT116 cells. Mater. Sci. Eng. C 2014, 39, 336–339. [CrossRef]
9. Chen, X.; Deng, C.; Tang, S.; Zhang, M. Mitochondria-Dependent Apoptosis Induced by Nanoscale Hydroxyapatite in Human
Gastric Cancer SGC-7901 Cells. Biol. Pharm. Bull. 2007, 30, 128–132. [CrossRef]
10. Benedini, L.; Placente, D.; Ruso, J.; Messina, P. Adsorption/desorption study of antibiotic and anti-inflammatory drugs onto
bioactive hydroxyapatite nano-rods. Mater. Sci. Eng. C 2019, 99, 180–190. [CrossRef]
11. Yedekci, Y.; Gedik, E.; Evis, Z.; Dogan, L.; Özyigit, G.; Gürkaynak, M. Radiosensitization induced by zinc-doped hydroxyapatite
nanoparticles in breast cancer cells. Int. J. Appl. Ceram. Technol. 2021, 18, 563–572. [CrossRef]
12. Dorozhkin, S.V. Nanosized and nanocrystalline calcium orthophosphates. Acta Biomater. 2010, 6, 715–734. [CrossRef]
13. Chahkandi, M.; Mirzaei, M. Structural and particle size evolution of sol–gel-derived nanocrystalline hydroxyapatite. J. Iran. Chem.
Soc. 2017, 14, 567–575. [CrossRef]
14. Lakrat, M.; Jabri, M.; Alves, M.; Fernandes, M.H.; Ansari, L.L.; Santos, C.; Mejdoubi, E.M. Three-dimensional Nano-
Hydroxyapatite sodium silicate glass composite scaffold for bone tissue engineering—A new fabrication process at a near-room
temperature. Mater. Chem. Phys. 2021, 260, 124185. [CrossRef]
15. Singh, B.; Dubey, A.K.; Kumar, S.; Saha, N.; Basu, B.; Gupta, R. In vitro biocompatibility and antimicrobial activity of wet
chemically prepared Ca10−x Agx (PO4 )6 (OH)2 (0.0 ≤ x ≤ 0.5) hydroxyapatites. Mater. Sci. Eng. C 2011, 31, 1320–1329. [CrossRef]
Nanomaterials 2022, 12, 856 13 of 14
16. Predoi, D.; Groza, A.; Iconaru, S.L.; Predoi, G.; Barbuceanu, F.; Guegan, R.; Motelica-Heino, M.S.; Cimpeanu, C. Properties of basil
and lavender essential oils adsorbed on the surface of hydroxyapatite. Materials 2018, 11, 652. [CrossRef]
17. Rumian, Ł.; Tiainen, H.; Cibor, U.; Krok-Borkowicz, M.; Brzychczy-Włoch, M.; Haugen, H.J.; Pamuła, E. Ceramic scaffolds with
immobilized vancomycin-loaded poly(lactide-co-glycolide) microparticles for bone defects treatment. Mater. Lett. 2017, 190,
67–70. [CrossRef]
18. Bi, Q.; Song, X.; Chen, Y.; Zheng, Y.; Yin, P.; Lei, T. Zn-HA/Bi-HA biphasic coatings on Titanium: Fabrication, characterization,
antibacterial and biological activity. Colloids Surf. B Biointerfaces 2020, 189, 110813. [CrossRef]
19. Huang, D.; Zuo, Y.; Zou, Q.; Zhang, L.; Li, J.; Cheng, L.; Shen, J.; Li, Y. Antibacterial chitosan coating on nano-
hydroxyapatite/polyamide66 porous bone scaffold for drug delivery. J. Biomater. Sci. Polym. Ed. 2011, 22, 931–944.
[CrossRef]
20. Malhotra, S.K. Nigella. In Handbook of Herbs and Spices; Woodhead Publishing: Thorston, UK, 2012; Volume 2, pp. 391–416.
21. Dalli, M.; Azizi, S.; Kandsi, F.; Gseyra, N. Evaluation of the in vitro antioxidant activity of different extracts of Nigella sativa L.
seeds, and the quantification of their bioactive compounds. Mater. Today Proc. 2021, 45, 7259–7263. [CrossRef]
22. Attaur-Rahman; Malik, S.; Zaman, K. Nigellimine: A new isoquinoline alkaloid from the seeds of nigella sativa. J. Nat. Prod. 1992,
55, 676–678. [CrossRef]
23. Atta-r-Rahman; Malik, S.; Hasan, S.S.; Choudhary, M.I.; Ni, C.Z.; Clardy, J. Nigellidine—A new indazole alkaloid from the seeds
of Nigella sativa. Tetrahedron Lett. 1995, 36, 1993–1996. [CrossRef]
24. Dalli, A.; Azizi, M.; Benouda, S.; Azghar, H.; Tahri, A.; Boufalja, M.; Maleb, B.; Gseyra, N. Molecular Composition and Antibacterial
Effect of Five Essential Oils Extracted from Nigella sativa L. Seeds against Multidrug-Resistant Bacteria: A Comparative Study.
Evid.-Based Complement. Altern. Med. 2021, 2021, 6643765. [CrossRef]
25. Mahmoudvand, S.A.; Sepahvand, H.; Jahanbakhsh, A.; Ezatpour, S.; Mousavi, B.A. Evaluation of antifungal activities of the
essential oil and various extracts of Nigella sativa and its main component, thymoquinone against pathogenic dermatophyte
strains. J. Mycol. Med. 2014, 24, e155–e161. [CrossRef]
26. Dalli, M.; Daoudi, N.E.; Azizi, S.; Benouda, H.; Bnouham, M.; Gseyra, N. Chemical Composition Analysis Using HPLC-UV/GC-
MS and Inhibitory Activity of Different Nigella sativa Fractions on Pancreatic α-Amylase and Intestinal Glucose Absorption.
BioMed Res. Int. 2021, 2021, 9979419. [CrossRef]
27. Michel, C.G.; El-Sayed, N.S.; Moustafa, S.F.; Ezzat, S.M.; Nesseem, D.I.; El-Alfy, T.S. Phytochemical and biological investigation of
the extracts of Nigella sativa L. seed waste. Drug Test. Anal. 2011, 3, 245–254. [CrossRef]
28. Bashir, M.U.; Qureshi, H.J. Analgesic effect of Nigella sativa seeds extract on experimentally induced pain in albino mice. J. Coll.
Physicians Surg. Pak. 2010, 20, 464–467.
29. Mann, C.M.; Markham, J.L. A new method for determining the minimum inhibitory concentration of essential oils. J. Appl.
Microbiol. 1998, 84, 538–544. [CrossRef]
30. Benataya, K.; Lakrat, M.; Elansari, L.L.; Mejdoubi, E. Synthesis of B-type carbonated hydroxyapatite by a new dissolution-
precipitation method. Mater. Today Proc. 2020, 31, S83–S88. [CrossRef]
31. Raita, M.S.; Iconaru, S.L.; Groza, A.; Cimpeanu, C.; Predoi, G.; Ghegoiu, L.; Badea, M.L.; Chifiriuc, M.C.; Marutescu, L.; Trusca, R.;
et al. Multifunctional Hydroxyapatite Coated with Arthemisia absinthium Composites. Molecules 2020, 25, 413. [CrossRef]
32. Drouet, C. Nanocrystalline apatites: From powders to biomaterials. Powder Technol. 2009, 190, 118–122. [CrossRef]
33. Man, R.; Santacroce, A.; Jacob, L.; Mare, L.; Man, A. Antimicrobial activity of six essential oils against a group of human pathogens:
A comparative study. Pathogens 2019, 8, 15. [CrossRef]
34. Zuridah, H.; Fairuz, A.R.M.; Zakri, A.H.Z.; Rahim, M.N.A. In vitro Antibacterial Activity of Nigella sativa Against Staphylococcus
aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli and Bacillus cereus. Asian J. Plant Sci. 2008, 7, 331–333.
[CrossRef]
35. Alam, M.M.; Yasmin, M.; Nessa, J.; Ahsan, C.R. Antibacterial activity of chloroform and ethanol extracts of black cumin seeds
(Nigella sativa) against multi-drug resistant human pathogens under laboratory conditions. J. Med. Plants Res. 2010, 4, 1901–1905.
36. Khalid, A.; Rehman, U.U.; Sethi, A.; Khilji, S.; Fatima, U.; Khan, M.I.; Waqas, M.K.; Saqib, Q.N.; Farzana, K.; Murtaza, G.; et al.
Antimicrobial activity analysis of extracts of Acacia modesta, Artimisia absinthium, Nigella sativa and Saussurea lappa against Gram
positive and Gram negative microorganisms. Afr. J. Biotechnol. 2011, 10, 4574–4580.
37. Abraham, A.O. Antimicrobial Activity of N-Hexane Extract of Nigella Sativa against Some Pathogenic Bacteria. Am. J. Biomed.
Sci. Res. 2019, 6, 430–434. [CrossRef]
38. Adamczak, A.; Ożarowski, M.; Karpiński, T.M. Antibacterial Activity of Some Flavonoids and Organic Acids Widely Distributed
in Plants. J. Clin. Med. 2019, 9, 109. [CrossRef]
39. Borges, A.; Ferreira, C.; Saavedra, M.J.; Simões, M. Antibacterial activity and mode of action of ferulic and gallic acids against
pathogenic bacteria. Microb. Drug Resist. 2013, 19, 256–265. [CrossRef]
40. Gopal, J.; Muthu, M.; Paul, D.; Kim, D.H.; Chun, S. Bactericidal activity of green tea extracts: The importance of catechin
containing nano particles. Sci. Rep. 2016, 6, 19710. [CrossRef]
41. McGaw, L.J.; Jäger, A.K.; van Staden, J. Antibacterial effects of fatty acids and related compounds from plants. S. Afr. J. Bot. 2002,
68, 417–423. [CrossRef]
42. Halawani, E. Antibacterial Activity of Thymoquinone and Thymohydroquinone of Nigella sativa L. and Their Interaction with
Some Antibiotics. Adv. Biol. Res. 2009, 3, 148–152.
Nanomaterials 2022, 12, 856 14 of 14
43. Mouwakeh, A.; Kincses, A.; Nové, M.; Mosolygó, T.; Mohácsi-Farkas, C.; Kiskó, G.; Spengler, G. Nigella sativa essential oil and its
bioactive compounds as resistance modifiers against Staphylococcus aureus. Phyther. Res. 2019, 33, 1010–1018. [CrossRef]
44. Ultee, A.; Bennik, M.H.J.; Moezelaar, R. The phenolic hydroxyl group of carvacrol is essential for action against the food-borne
pathogen Bacillus cereus. Appl. Environ. Microbiol. 2002, 68, 1561–1568. [CrossRef] [PubMed]
45. Tariq, W.; Wani, S.; Rasool, S.; Shafi, M.A.; Bhat, K.; Prabhakar, M.A.; Shalla, A.; Rather, A.H. A comprehensive review of the
antibacterial, antifungal and antiviral potential of essential oils and their chemical constituents against drug-resistant microbial
pathogens. Microb. Pathog. 2019, 134, 103580. [CrossRef] [PubMed]